(Q48708390)

14 February 2018

title

Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion. (English)

1 reference

14 February 2018

1 reference

5

Blundell J

1 reference

14 February 2018

Greenough A

1

1 reference

14 February 2018

Cole G

series ordinal

2

1 reference

14 February 2018

Lewis J

series ordinal

3

1 reference

14 February 2018

Lockton A

series ordinal

4

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

14 February 2018

published in

Physiology & Behavior

1 reference

14 February 2018

volume

65

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

303-310

1 reference

14 February 2018

Cholecystokinin-4 and panic.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Increased food intake after type A but not type B cholecystokinin receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Immunochemical evidence of cholecystokinin-like peptides in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Cholecystokinin-decreased food intake in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Cholecystokinin decreases food intake in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Duodenal infusion of fat, cholecystokinin secretion and satiety in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

C-terminal octapeptide of cholecystokinin decreases food intake in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Satiety effects of a physiological dose of cholecystokinin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Blood-brain barrier permeability to peptides: Pitfalls in measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

C-Terminal octapeptide of cholecystokinin decreases food intake in obese men☆☆☆

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Identification of cholecystokinin-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Endogenous cholecystokinin reduces feeding in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2898%2900169-3

7 January 2021

10.1016/S0031-9384(98)00169-3

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9855480

1 reference

14 February 2018